News | News By Subject | News by Disease News By Date | Search News

 News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
EXCLUSIVE: Pediatric Patients Could Benefit Most From New Oncoceutics Cancer Drug, Says Exec     7/2/2015
Evotec AG (EVTG.F), Roche (RHHBY)'s Alzheimer's Hopeful Fails Another Trial     7/1/2015
Vitae Pharma (VTAE)’ Diabetes Drug Fails Mid-Stage Trial, the Second Drug in Less Than Six Months to Fail     6/29/2015
Aquinox (AQXP)’s Bladder Pain Drug Fails to Meet Statistical Endpoint in Phase II Trial     6/25/2015
Vical  (VICL) Herpes Vaccine Clinical Trial Disappoints with "Confounding Results"     6/24/2015
Alcobra (ADHD)’s Fragile X Syndrome Drug Fails During Mid-Stage Trial     6/24/2015
BioMarin (BMRN) Surging on Impressive Phase II Dwarfism Data     6/22/2015
bluebird bio (BLUE) Surges as Pioneering Sickle Cell Gene Therapy Working for 13-Year-Old French Boy     6/18/2015
Analysts Question Avalanche Biotech (AAVL) Clinical Data, Could Jeopardize Regeneron (REGN) Deal     6/18/2015
Eli Lilly (LLY) Hits 14-Year High as Investors Await Alzheimer's Data     6/16/2015
bluebird bio (BLUE) Defies RAC Panel's Recommendation, Will Proceed With Two Planned Trials     6/11/2015
SAGE Therapeutics (SAGE) Soars as Postpartum Depression Disappears in Four New Mothers     6/10/2015
Bay Area's Ardelyx (ARDX) Will Go It Alone on GI Drug As it Splits With AstraZeneca PLC (AZN)     6/4/2015
ASCO15 EXCLUSIVE: Experimental Brain Cancer Drugs Heads to Phase II/III Trial This Year: DelMar Pharmaceuticals CEO     6/3/2015
ASCO15: Tiny Clovis Oncology (CLVS) Becomes an Even Bigger Takeover Target as Ovarian Cancer Drug Shrunk Tumors in 82% of Women     6/2/2015

Featured Stories
Why Investors Shouldn't Freak Out Over Vertex (VRTX)'s Latest Trial Results     3/24/2015
Newcomers Like Aerie Pharmaceuticals, Inc. (AERI), Inotek Pharmaceuticals Corporation Aim to Shake Up Big Pharma With New Wave of Glaucoma Drugs     2/10/2015
OncoGenex Pharmaceuticals Inc. (OGXI) Retrenches, And Searches For Answers, After Failed Trial     5/22/2014
Rumor: Will Pfizer Inc. (PFE) Unveil A Breast Cancer Blockbuster At American Association for Cancer Research?     4/4/2014
Popular Weight-Lifting Supplement May Slow Huntington Disease, Massachusetts General Hospital Study     2/11/2014
Dawn of A New Sleep Drug at Merck & Co., Inc. (MRK)?     7/19/2011
Cancer Trial Patients Take Rosy View of Likely Benefit, Oregon Health & Science University (OHSU) Study     1/28/2011
Experimental Drug Panobinostat Shows Little Activity In MDS Patients, Sarah Cannon Research Institute Study     12/30/2010
Cytokinetics, Inc. (CYTK) Drug Helps ALS Patients in Small Trial     12/13/2010
American Society of Hematology: Novel Hodgkin Drug 'Dramatic' in Refractory Patients, City of Hope Study     12/7/2010
American College of Rheumatology: Anti-IL17 Drug Misses Endpoint in RA Trial, Stanford University Study     11/11/2010
American Association for Study of Liver Diseases: Early Study Shows HCV Vaccine Works, Scripps Clinic Study     11/3/2010
American Association for Study of Liver Diseases: Rapid Response for Once-Daily Protease Inhibitor, University of North Carolina Study     11/3/2010
American Academy of Ophthalmology: Glaucoma Drug Passes Early Clinical Test     10/21/2010
Ceregene, Inc. Initiates a New Controlled Phase 2b Trial of Cere-120 for Parkinson's Disease     10/19/2010
Avexxin Completes Phase I/IIA Study In Psoriasis And Achieves Proof-Of-Concept In Man With Its Compound AVX001 In A Topical Formulation     7/2/2015
Cyclacel Pharmaceuticals, Inc. (CYCC) Release: First Patient Dosed In IST Of CDK Inhibitor Seliciclib In Cushing's Disease, A Serious Endocrine Disorder     7/2/2015
Teva (TEVA) And Xenon Pharmaceuticals Inc. Provide Update On TV-45070 Phase IIb Study In Osteoarthritis Pain     7/1/2015
TetraLogic Pharmaceuticals (TLOG) Announces Update On MDS Clinical Program     7/1/2015
VistaGen Therapeutics, Inc. Receives FDA And NIH Clearance To Initiate NIH-Funded Phase 2 Study Of Orally Active AV-101 In Major Depressive Disorder     7/1/2015
Oramed Pharmaceuticals Inc. (ORMP) Submits Protocol To U.S. FDA For Its Phase Ilb Oral Insulin Study     6/30/2015
Oramed Pharmaceuticals Inc. (ORMP) Enrolls First Patient In Its Phase Ilb Oral Insulin Study     6/30/2015
BiondVax Pharmaceuticals Presents BVX-006 Preliminary Phase II Results: The Universal Flu Vaccine At Higher Doses Is Safe And Improves Immunogenicity In Older Adults     6/30/2015
Pharma Two B Ltd. Announces Positive Results In Its Phase Ilb Pivotal Clinical Study Of P2B001 For The Treatment Of Early Stage Parkinson's Disease     6/30/2015
Replicel Life Sciences Enrolls First Participant In Phase 1/2 Clinical Trial Of RCT-01 For Chronic Achilles Tendinosis     6/30/2015
Anavex (AVXL) To Present Initial Clinical Data From The Phase IIa Clinical Trial Of ANAVEX 2-73 At The Alzheimer’s Association International Conference (AAIC)     6/30/2015
Synthetic Biologics, Inc. (SYN)' Initiates SYN-010 Phase 2 Clinical Trial To Treat Irritable Bowel Syndrome With Constipation (IBS-C)     6/29/2015
Aratana Therapeutics (PETX) Announces Positive Pivotal Results For AT-002     6/29/2015
Aduro Biotech (ADRO) Announces Immunotherapy Regimen Successfully Passes Futility Analysis In Phase IIb ECLIPSE Trial In Metastatic Pancreatic Cancer     6/29/2015
Vitae Pharma (VTAE) Announces Top-Line Results From Metformin Arm of Ongoing Phase II Clinical Trial of BI187004/VTP-34072 in Overweight Type 2 Diabetics     6/29/2015

More News
No News Posted on that date

Career Tips
CombiMatrix (CBMX) Will Nearly Double Staff in 2015 As Hiring Roars, CEO Says     6/25/2015
3 Skills You Need to Succeed in the Biotech Industry     6/25/2015
5 Hiring Tricks Revealed     6/25/2015
Northern California Readies for Talent Connect As Biotech Bay Booms     6/15/2015
3 Unexpected New Ways to Revamp Your Resume     6/11/2015
Radius Health (RDUS) Plans to Double Staff in 2015, Exec Tells BioSpace (DHX)     6/11/2015
The Most Exciting Companies in Biotech     6/1/2015
Corbus Will Interview Twice as Many Candidates in 2015 as Its Ranks Grow     5/29/2015
HR Exec Says Alder Biopharma Will Grow 30% in 2015, As Hunt for Candidates Continues     5/15/2015
The After-Interview Trick You’re Not Using     5/14/2015
New Networking Opportunities at Talent Connect, Over 600 Bioscience Jobs Available Now     5/14/2015
THERAVECTYS Upped Hiring Almost Five-Fold in 2014, As Biotech Booms, Says HR Head     5/1/2015
4 Phrases You’ll Need at Your Next Networking Event     4/30/2015
Avoid a Job Mismatch     4/30/2015
Sucampo (SCMP) Looks to Add to "Scientific Core" As Global Reach Grows, Says HR     4/16/2015

Other News Sources
//-->